CHATTEM INC
10-Q, EX-27, 2000-07-14
PHARMACEUTICAL PREPARATIONS
Previous: CHATTEM INC, 10-Q, EX-11, 2000-07-14
Next: CHATTEM INC, 10-Q, EX-99, 2000-07-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CHATTEM,
INC.'S UNAUDITED FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                                    6-MOS
<FISCAL-YEAR-END>                          NOV-30-2000
<PERIOD-START>                             DEC-01-1999
<PERIOD-END>                               MAY-31-2000
<CASH>                                           2,325
<SECURITIES>                                         0
<RECEIVABLES>                                   62,312
<ALLOWANCES>                                       850
<INVENTORY>                                     25,129
<CURRENT-ASSETS>                                97,085
<PP&E>                                          49,923
<DEPRECIATION>                                  21,017
<TOTAL-ASSETS>                                 491,712
<CURRENT-LIABILITIES>                           59,466
<BONDS>                                        360,864
                                0
                                          0
<COMMON>                                         1,977
<OTHER-SE>                                      52,030
<TOTAL-LIABILITY-AND-EQUITY>                   491,712
<SALES>                                        142,007
<TOTAL-REVENUES>                               142,007
<CGS>                                           38,137
<TOTAL-COSTS>                                  108,134
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              18,190
<INCOME-PRETAX>                                 15,810
<INCOME-TAX>                                     5,983
<INCOME-CONTINUING>                              9,827
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  (110)
<CHANGES>                                        (542)
<NET-INCOME>                                     9,175
<EPS-BASIC>                                        .95
<EPS-DILUTED>                                      .94


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission